2020 Sino-American International Cancer Research Conference
Invitation
Dear Friends and Colleagues,
“2020 Sino-American International Cancer Research Conference” will be held from April 10th to 12nd, 2020 in Shenzhen, China. The conference is hosted by Shenzhen University and organized by the Shenzhen University International Cancer Center.
This conference invites famous experts from basic research, translational research and clinical research to update latest advance in cancer fields, which mainly focuses on "pathogenesis, targeted therapy and immunotherapy ". It aims to provide the majority of peers with the understanding of "the key pathogenic mechanism to promote cancer progression and relapse, the mechanism of action of related therapeutic drugs and the new progress in cancer therapy". The platform for the majority of scientific researchers and clinicians presented an academic feast.
We sincerely invite researchers and clinicians to participate in this exciting event for scientific information exchange and to build new international collaborations.
Shenzhen University International Cancer Center
Conference organization committee
Organized by:
Shenzhen University International Cancer Center
Shenzhen University Health Science Center
Hosted by:
Shenzhen University
Conference president:
Dr. Wei-Guo Zhu
Joint presidents:
Dr. Li Yu
Dr. Zhi-Ming Cai
Co-organizers:
Dr. Su-Ping Zhang
Scientific committee:
Dr. Wei-Guo Zhu
Dr. Li Yu
Dr. Zhi-Ming Cai
Dr. De-Sheng Lu
Dr. Guang-Yi Jin
Dr. Li Fu
Dr. Zhi-Cao Yue
Dr. Su-Ping Zhang
Dr. Teawan Kim
Secretaries:
Mr. Benjamin Carson
Ms. Ni-Na Liao
Mr. Bing-Ming Zhao
Information
Conference date: Shenzhen University Xili Campus, 10th -12th April, 2020
Registration: April 10th, 2020
Symposium venue: Conference Hall, A5 Block, Shenzhen University Lihu Campus
Address: No. 1066, Xue Yuan Avenue, Xili University Town, Nanshan District, Shenzhen.
Invited speakers
Woojin An | Professor of Biochemistry & Molecular Medicine University of Southern California, USA |
Topic | Chromatin dynamics and epigenetic gene regulation |
|
|
|
|
Carlo M. Croce | Distinguished University Professor The John W. Wolfe Chair in Human Cancer Genetics, The Ohio State University, USA Membership in National Academy of Science Membership in National Academy of Medicine Membership in National Academy of Inventors AAAS (American Association for the Advancement of Science) Fellow AAAS (American Academy of Arts & Sciences) Fellow AACR (American Association for Cancer Research) Academy Fellow |
|
|
|
|
Hong-Bin Ji | Researcher, Shanghai Institute of Biochemistry and Cell Biology, CAS, China |
|
|
|
|
Thomas J. Kipps | Distinguished Professor of Medicine Deputy Director,Research Operations UC San Diego Moores Cancer Center, USA |
|
|
|
|
Heinz-Josef Lenz | Professor of Medicine J. Terrence Lanni Chair in Gastrointestinal Cancer Res. Co-Director, USC Center for Molecular Pathway and Drug Discovery University of Southern California, USA |
Topic | Molecular Landscape of Metastatic Colorectal Cancer |
|
|
|
|
Qun-Ying Lei | Professor, Fudan University, China |
|
|
Meng-Feng Li | President, Southern Medical University, China |
|
|
Gangning Liang | Professor of Department of Urology Director of Epigenetic Translational Res. Inst. of Urology University of Southern California, USA |
Topic | Targeting Epigenetic Alterations in Cancer Treatment |
|
|
|
|
Guo-Liang Qing | Professor, Medical Research Institute, Wuhan University, China |
|
|
Pann-Ghill Suh | President, Korea Research Institute of Brain, South Korea National Great Scholar, South Korea Committee Chair of the National Basic Science Project, The Ministry of Science and ICT of the Government of South Korea Committee Chair of the National Training Project for Women Scientists, The Ministry of Education of the Government of South Korea |
Topic | The Role of Phospholipase C involved in Colorectal Tumor Development |
|
|
|
|
Shunichi Takeda | Professor of Department of Radiation Genetics Kyoto University, Japan |
Topic | BRCA1 ensures genome integrity by eliminating estrogen-induced pathological Topoisomerase II-DNA complexes |
|
|
|
|
Daniel Tenen | Professor of Dept. of Medicine, Harvard Medical School Distinguished Professor, Department of Medicine National University of Singapore Director, Cancer Science Institute of Singapore |
Topic | Targeting SALL4 in cancer |
|
|
|
|
TEH Bin Tean | Deputy Director (Research), National Cancer Centre Singapore Deputy Director (Scientific), SingHealth Duke-NUS Institute of Precision Medicine Professor, Duke-NUS Medical School, Singapore Senior Principal Investigator, Cancer Science Institute of Singapore Senior Principal Investigator, Institute of Molecular and Cell Biology, Singapore |
Topic | Epigenetic Studies of Renal Cell Carcinoma |
|
|
|
|
Toshikazu Ushijima | Chief, Division of Epigenomics National Cancer Center Research Institute, Japan |
Topic | The very beginning of gastric cancer: accumulation of aberrant DNA methylation in normal tissue |
|
|
|
|
Weiping Zou | Charles B. de Nancrede Prof. of Surgery, Immun. and Biol. Co-Director, Tumor Immun. and Transplant. Biol. Program University of Michigan, USA |
Updating…
用户登录
还没有账号？
立即注册